Experience

General Inception

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Co-Founder, President & COO

  • 2020 - Present



Genoa Ventures

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Partner

  • 2019 - Present



SimBioSys, Inc.

• United States
• Biotechnology
• 1 - 100 Employee

• Board Member

  • 2021 - Present



Epitel

• United States
• Biotechnology Research
• 1 - 100 Employee

• Board Member

  • 2022 - Present



BRAINBox Solutions, Inc.

• United States
• Biotechnology
• 1 - 100 Employee

• Board Member

  • 2021 - Present

• Board Observer

  • 2020 - 2021



Nureca Limited (Dr Trust)

• India
• Retail Health and Personal Care Products
• 1 - 100 Employee

• Independent Director

  • 2021 - Present



Ionpath

• United States
• Biotechnology Research
• 1 - 100 Employee

• Board Observer

  • 2019 - Present



Attune Neurosciences, Inc.

• United States
• Medical Device
• 1 - 100 Employee

• Investor

  • 2021 - Present



Lam Research

• United States
• Semiconductor Manufacturing
• 700 & Above Employee

• Head of Life Sciences

  • 2017 - 2019

  Formulate acquisition strategy to build a new Life Sciences division for Lam Research, a leader in the semiconductor tools market. ► Led evaluation of new business opportunities for Lam in the life sciences industry. ++Led Lam's Life Sciences strategy in emerging businesses, corporate development ++Led all strategic planning activities across Genomics, Proteomics, Bioinformatics, Sample prep and Synthetic Biology: Market evaluation, segmentation, customer… Show more Formulate acquisition strategy to build a new Life Sciences division for Lam Research, a leader in the semiconductor tools market. ► Led evaluation of new business opportunities for Lam in the life sciences industry. ++Led Lam's Life Sciences strategy in emerging businesses, corporate development ++Led all strategic planning activities across Genomics, Proteomics, Bioinformatics, Sample prep and Synthetic Biology: Market evaluation, segmentation, customer unmet needs, competitive analysis, technology diligence and strategic road mapping. ► Led all deal sourcing and deal structuring activities for investments, joint development agreements and acquisitions in life sciences ++Led all Life Sciences venture investments including Lam Antheia, Mission Bio, Ominiome ++Led the sourcing and diligence for joint development partnership with Nanostring ► Oversaw all investments and partnerships post close ++Member of joint-steering committee for partnership with Nanostring ++Primary business lead for all partnerships and investments ++Managed investment performance and fielded all support needs from engineering, nanofabrication and operations. ► Built scientific and commercial advisory boards and oversaw all consultancy partnerships ► Built and maintained relationships between venture, private organizations and academic institutions across the US and European innovation ecosystem Show less Formulate acquisition strategy to build a new Life Sciences division for Lam Research, a leader in the semiconductor tools market. ► Led evaluation of new business opportunities for Lam in the life sciences industry. ++Led Lam's Life Sciences strategy in emerging businesses, corporate development ++Led all strategic planning activities across Genomics, Proteomics, Bioinformatics, Sample prep and Synthetic Biology: Market evaluation, segmentation, customer… Show more Formulate acquisition strategy to build a new Life Sciences division for Lam Research, a leader in the semiconductor tools market. ► Led evaluation of new business opportunities for Lam in the life sciences industry. ++Led Lam's Life Sciences strategy in emerging businesses, corporate development ++Led all strategic planning activities across Genomics, Proteomics, Bioinformatics, Sample prep and Synthetic Biology: Market evaluation, segmentation, customer unmet needs, competitive analysis, technology diligence and strategic road mapping. ► Led all deal sourcing and deal structuring activities for investments, joint development agreements and acquisitions in life sciences ++Led all Life Sciences venture investments including Lam Antheia, Mission Bio, Ominiome ++Led the sourcing and diligence for joint development partnership with Nanostring ► Oversaw all investments and partnerships post close ++Member of joint-steering committee for partnership with Nanostring ++Primary business lead for all partnerships and investments ++Managed investment performance and fielded all support needs from engineering, nanofabrication and operations. ► Built scientific and commercial advisory boards and oversaw all consultancy partnerships ► Built and maintained relationships between venture, private organizations and academic institutions across the US and European innovation ecosystem Show less



McKinsey & Company

• Business Consulting and Services
• 700 & Above Employee

• Engagement Manager

  • 2013 - 2017

  Management consulting to myriad of clients from Fortune 500 to startup. Led teams of industry experts, client executives and consultants to solve critical business problems for Fortune 500 Life Sciences corporations and leading biotechnology startup companies across the world. A handful of examples : ► Growth strategy for a Fortune 500 company ++Led in depth market analysis across Life Sciences ++ Led identification and diligence of minority… Show more Management consulting to myriad of clients from Fortune 500 to startup. Led teams of industry experts, client executives and consultants to solve critical business problems for Fortune 500 Life Sciences corporations and leading biotechnology startup companies across the world. A handful of examples : ► Growth strategy for a Fortune 500 company ++Led in depth market analysis across Life Sciences ++ Led identification and diligence of minority investments, partnerships and acquisitions ++ Developed a portfolio based risk analysis approach for assessing assessing execution options ► Growth strategy for a med device company ++ Delivered sales strategies and launched pilot initiatives for 50+% growth two major assets into clinical space ► Growth and R&D strategy for a startup biotech ++ Streamlined a R&D strategy for clinical trials ++ Developed a financial forecasting tool for risked based analysis to inform portfolio expansion ► Due Diligence for major merger for a major pharma company ++ Pre-merger diligence and post merger synergy and transformation focused on operations strategy and supplier collaboration efforts ► Due diligence activity for healthcare private equity ++ Led Synergy assessment, deal structuring ++ Developed post acquisition transformation plan ► Comprehensive strategic sourcing transformation effort for a major Life Sciences company ++ Led restructuring of sourcing strategy for pharmacy, consumer medical devices and medical diagnostic equipment etc. ► Due-diligence and post merger integration in life sciences ++ Evaluated pre-merger synergy opportunities ++ Developed post-merger operating model, combined sourcing strategy, optimizing internal and external manufacturing and quality organization footprint Show less Management consulting to myriad of clients from Fortune 500 to startup. Led teams of industry experts, client executives and consultants to solve critical business problems for Fortune 500 Life Sciences corporations and leading biotechnology startup companies across the world. A handful of examples : ► Growth strategy for a Fortune 500 company ++Led in depth market analysis across Life Sciences ++ Led identification and diligence of minority… Show more Management consulting to myriad of clients from Fortune 500 to startup. Led teams of industry experts, client executives and consultants to solve critical business problems for Fortune 500 Life Sciences corporations and leading biotechnology startup companies across the world. A handful of examples : ► Growth strategy for a Fortune 500 company ++Led in depth market analysis across Life Sciences ++ Led identification and diligence of minority investments, partnerships and acquisitions ++ Developed a portfolio based risk analysis approach for assessing assessing execution options ► Growth strategy for a med device company ++ Delivered sales strategies and launched pilot initiatives for 50+% growth two major assets into clinical space ► Growth and R&D strategy for a startup biotech ++ Streamlined a R&D strategy for clinical trials ++ Developed a financial forecasting tool for risked based analysis to inform portfolio expansion ► Due Diligence for major merger for a major pharma company ++ Pre-merger diligence and post merger synergy and transformation focused on operations strategy and supplier collaboration efforts ► Due diligence activity for healthcare private equity ++ Led Synergy assessment, deal structuring ++ Developed post acquisition transformation plan ► Comprehensive strategic sourcing transformation effort for a major Life Sciences company ++ Led restructuring of sourcing strategy for pharmacy, consumer medical devices and medical diagnostic equipment etc. ► Due-diligence and post merger integration in life sciences ++ Evaluated pre-merger synergy opportunities ++ Developed post-merger operating model, combined sourcing strategy, optimizing internal and external manufacturing and quality organization footprint Show less



Stealth Mode

• 700 & Above Employee

• Co-Founder and Head of Product

  • 2012 - 2013



Krayons Marketing Pvt. Ltd

• Co-Founder and Director

  • 2006 - 2013

  Co-founded private company, valued at $10M, for marketing industrial equipment nationally. Identified market opportunity for industrial equipment. ++Boosted sales by 80% annually. Seized investment opportunities in real-estate market. ++Increased earnings per share by 180% in 3 years. Co-founded private company, valued at $10M, for marketing industrial equipment nationally. Identified market opportunity for industrial equipment. ++Boosted sales by 80% annually. Seized investment opportunities in real-estate market. ++Increased earnings per share by 180% in 3 years.



Parabolic Drugs

• India
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Manager US Technology and Business Development

  • 2011 - 2012

  Researched pharmaceutical drug markets to identify potential targets for contracted research and reported to EVP for US technology and business development department of a $170M pharmaceutical company. Assessed viability of potential target drugs in high-potency pharmaceutical industries. Enhanced ability to obtain new contracts and extend existing customer relationships through an iterative adaptation strategy of market demands. Doubled number of new contracts in 2011. Advised R&D… Show more Researched pharmaceutical drug markets to identify potential targets for contracted research and reported to EVP for US technology and business development department of a $170M pharmaceutical company. Assessed viability of potential target drugs in high-potency pharmaceutical industries. Enhanced ability to obtain new contracts and extend existing customer relationships through an iterative adaptation strategy of market demands. Doubled number of new contracts in 2011. Advised R&D branch on investments in state-of-the-art technology to maintain competitive advantage. Show less Researched pharmaceutical drug markets to identify potential targets for contracted research and reported to EVP for US technology and business development department of a $170M pharmaceutical company. Assessed viability of potential target drugs in high-potency pharmaceutical industries. Enhanced ability to obtain new contracts and extend existing customer relationships through an iterative adaptation strategy of market demands. Doubled number of new contracts in 2011. Advised R&D… Show more Researched pharmaceutical drug markets to identify potential targets for contracted research and reported to EVP for US technology and business development department of a $170M pharmaceutical company. Assessed viability of potential target drugs in high-potency pharmaceutical industries. Enhanced ability to obtain new contracts and extend existing customer relationships through an iterative adaptation strategy of market demands. Doubled number of new contracts in 2011. Advised R&D branch on investments in state-of-the-art technology to maintain competitive advantage. Show less



University of Illinois Urbana-Champaign

• United States
• Higher Education
• 700 & Above Employee

• Graduate Research Assistant

  • 2009 - 2012

  Led research for early detection of cancer blood biomarkers project. Oversaw development of specialized instrument from conception of idea through completion. Projected to improve ability to detect cancer by 10X vs. current tools at only 15% of the cost. Proposed and implemented new approach using analysis of multiple proteins for early detection of breast cancer to improve patient survival rate. Created novel method for label-free detection of cellular attachment for cell kinetics… Show more Led research for early detection of cancer blood biomarkers project. Oversaw development of specialized instrument from conception of idea through completion. Projected to improve ability to detect cancer by 10X vs. current tools at only 15% of the cost. Proposed and implemented new approach using analysis of multiple proteins for early detection of breast cancer to improve patient survival rate. Created novel method for label-free detection of cellular attachment for cell kinetics study.

• Student Body Vice President

  • 2008 - 2009

  Supervised 4 student government departments totaling 40 members as executive for 40K+ student body. Developed first public voting records for elected senators, improving transparency of student government.



Acme Tele-Power Ltd

• Intern

  • May 2006 - Aug 2006

  Worked in the research and development department. Organized research on the Power Interface Unit. Researched the materials and design specifications for building a nano-cooled Green Shelter. Worked in the research and development department. Organized research on the Power Interface Unit. Researched the materials and design specifications for building a nano-cooled Green Shelter.